COVID-19 Associated Vasculitis Confirmed by the Tissues RT-PCR: A Case Series Report

Konstantin E Belozerov1, Ilia S Avrusin1, Lyubov I Andaryanova1

  • 1Hospital Pediatry, Saint Petersburg State Pediatric Medical University, 194100 Saint Petersburg, Russia.

Biomedicines
|March 29, 2023
PubMed

Insights

COVID-19 in children can cause serious vasculitis affecting multiple organs, including skin and the central nervous system. Early diagnosis and treatment with steroids and immunomodulators are crucial for managing this life-threatening condition.

Area of Science:

  • Pediatric Rheumatology
  • Infectious Diseases
  • Vascular Medicine

Background:

  • Limited data exists on COVID-19-associated vasculopathy in children.
  • Skin and central nervous system involvement has been reported.
  • This study describes cases of pediatric vasculitis linked to COVID-19.

Purpose of the Study:

  • To characterize COVID-19-associated vasculitis in pediatric patients.
  • To describe the clinical presentation, affected systems, and treatment outcomes.

Main Methods:

  • Retrospective-prospective case series.
  • Inclusion of four pediatric patients with confirmed COVID-19-associated vasculitis.
  • Morphological description and etiological confirmation via RT-PCR on tissue biopsy.

Main Results:

  • Skin (100%), respiratory (75%), and cardiovascular (50%) systems were most frequently involved.
  • All patients exhibited elevated inflammatory markers and D-dimer.
  • Diagnoses included polyarteritis nodosa (50%), Henoch-Schonlein purpura (25%), and unclassified vasculitis (25%).
  • Treatment involved systemic glucocorticosteroids, DMARDs, and in some cases, IVIG or biologics (etanercept, tocilizumab, adalimumab).

Conclusions:

  • COVID-19-associated vasculitis can be life-threatening in children.
  • SARS-CoV-2 may act as a trigger for vasculitis and immune-mediated diseases.
  • Further research and case collection are necessary to understand this condition.
Abstract

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
14
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
41
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
14